About   Subscribe   Submit   My BJ   Librarians   Authors   Readers   Help



Editorial Board
Chair
PR Shepherd - Auckland

Vice Chair, The Americas
G Salvesen - La Jolla, CA

Vice Chair, Asia-Pacific
T Xu - Beijing

Vice Chair, Europe
DR Alessi - Dundee

Vice Chair, Reviews
A Toker - Boston, MA

Deputy Chairs
M Blatt - Glasgow
D Carling - London
JF Cáceres - Edinburgh
L Goodyear - Boston, MA
D Hoekstra - Groningen
S Huber - Urbana, IL
J Ladbury - Houston, TX
M Lemmon - Philadelphia, PA
C MacKintosh - Dundee
M Murphy - Cambridge
S Roberts - Buffalo, NY
M Schwartz - New Haven, CT
D Tosh - Bath
D van Aalten - Dundee
B Vanhaesebroeck - London
HM Wallace - Aberdeen
MF White - St Andrews

To help you get the best out of your visit to the Biochemical Journal, papers are divided into nine knowledge environments: Cell, ChemBio,Disease, Energy, Gene, Metabolism, Plant, Signal, Structure

With an Impact Factor of 5.016 there has never been a better time to submit your next paper to us.
Submit your next paper and find out what publishing benefits we offer...
San Diego, February 25-29
Visit us at Booth #333 for your chance to win an Apple iPad 2! In gratitude to the Sanford-Burnham Medical Research Institute for hosting its US Editorial Office, the Biochemical Journal is sponsoring a special one-day symposium at the Institute in La Jolla, CA on Thursday March 22nd 2012. View speaker list and pre-register.
SEMANTIC BJ VIDEO DEMO
The Semantic Biochemical Journal brings PDFs to life and will revolutionize the way we interact with the scholarly scientific journal forever. See the revolution for yourself - video demo now available
Opt2Pay The Biochemical Journal is fully compliant with funding body mandates including NIH. Read our FAQs

In this BJ Signal paper, Thimo Kurz and colleagues report a new mode of NEDD8 conjugation ('NEDDylation') whereby this ubiquitin-like modifier protein is linked to proteins by ubiquitin enzymes in vitro.

In this BJ ChemBio paper, which is freely available to all authors, Martin Crompton and colleagues report the synthesis of a modified mitochondrial-targeted CsA (cyclosporin A) with a much-improved cyclophilin D binding affinity relative to the prototype, and show how it yields better cytoprotection than CsA in an isolated cardiomyocyte model of reperfusion injury.

In this BJ Gene paper, Matthew Brook, Nicola Gray and colleagues show that human PABP1 [poly(A)-binding protein 1] is subject to elaborate post-translational modification, and have identified 14 novel modifications located throughout the functional domains, all but one of which are conserved in mouse.

 

 

 

Chinese users - get faster access here